Phase III Clinical Study of Efficacy and Safety of Vaccae™ to Prevent Tuberculosis
Phase III Clinical Study of Efficacy and Safety of Mycobacterium Vaccae to Prevent Tuberculosis in High Risk Groups of Tuberculosis Infection
Sponsor: Air Force Military Medical University, China
Listed as NCT01979900, this PHASE3 trial focuses on Tuberculosis and remains completed. Sponsored by Air Force Military Medical University, China, it has been updated 12 times since 2013, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
12 versions recorded-
Dec 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Dec 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Oct 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Oct 2021 [monthly]
Completed PHASE3
▶ Show 7 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Completed PHASE3
-
Jul 2018 — Nov 2020 [monthly]
Completed PHASE3
Status: Unknown Status → Completed
-
Jun 2018 — Jul 2018 [monthly]
Unknown Status PHASE3
Status: Recruiting → Unknown Status
-
Dec 2017 — Jun 2018 [monthly]
Recruiting PHASE3
Status: Unknown Status → Recruiting
-
Sep 2017 — Dec 2017 [monthly]
Unknown Status PHASE3
Status: Active Not Recruiting → Unknown Status
-
Feb 2017 — Sep 2017 [monthly]
Active Not Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE3
First recorded
Oct 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Air Force Military Medical University, China
- Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
- Guangxi Center for Disease Control and Prevention
- Jin Chengjiang Center for Disease Control and Prevention,China
- Liucheng County Disease Control and Prevention,China
- Liuzhou Center for Disease Control and Prevention,China
- National Institutes for Food and Drug Control, China
- Rongshui County Disease Control and Prevention,China
- Simoon Record Pharma Information Consulting Co., Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .